2-Apr-2026
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member
Globe Newswire (Thu, 2-Apr 8:00 AM ET)
Deutsche Bank Keeps Their Hold Rating on Koninklijke Philips N.V. (0LNG)
TipRanks (Wed, 1-Apr 8:38 AM ET)
J.P. Morgan Sticks to Its Hold Rating for Koninklijke Philips N.V. (0LNG)
TipRanks (Wed, 1-Apr 6:16 AM ET)
Bernstein Keeps Their Hold Rating on Koninklijke Philips N.V. (0LNG)
TipRanks (Tue, 31-Mar 7:45 AM ET)
Barclays Keeps Their Buy Rating on Koninklijke Philips N.V. (0LNG)
TipRanks (Tue, 31-Mar 2:36 AM ET)
Philips Refreshes Supervisory Board and Seeks CEO Re-Appointment Ahead of May 2026 AGM
TipRanks (Mon, 30-Mar 1:48 PM ET)
Philips Sets May 8, 2026 AGM to Vote on Board, CEO Reappointment and Dividend
TipRanks (Mon, 30-Mar 1:47 PM ET)
Globe Newswire (Thu, 26-Mar 9:10 AM ET)
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
Globe Newswire (Wed, 25-Mar 5:00 AM ET)
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
Globe Newswire (Tue, 24-Mar 4:30 AM ET)
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Koninklijke Philips N.V. Ny Registry Shares trades on the NYSE stock market under the symbol PHG.
As of April 2, 2026, PHG stock price declined to $27.11 with 881,534 million shares trading.
PHG has a beta of 1.22, meaning it tends to be more sensitive to market movements. PHG has a correlation of 0.45 to the broad based SPY ETF.
PHG has a market cap of $25.77 billion. This is considered a Large Cap stock.
Last quarter Koninklijke Philips N.V. Ny Registry Shares reported $6 billion in Revenue and $.70 earnings per share. This beat revenue expectation by $120 million and exceeded earnings estimates by $.16.
In the last 3 years, PHG traded as high as $33.44 and as low as $17.74.
The top ETF exchange traded funds that PHG belongs to (by Net Assets): DFIV, DFIC, DFAI, AVDE, BINV.
PHG has underperformed the market in the last year with a return of +12.8%, while SPY returned +17.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PHG shares. However, PHG has outperformed the market in the last 3 month and 2 week periods, returning +0.1% and +0.9%, while SPY returned -3.7% and -0.1%, respectively. This indicates PHG has been having a stronger performance recently.
PHG support price is $26.72 and resistance is $27.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHG shares will trade within this expected range on the day.